Daniel C. Martin, Chief Commercial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 53,998 shares at $67.18 ($3.6M) on 2020-01-22, disclosed to the SEC on 2020-01-24.
Open-market sale of $3.6M DCPH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.18 | 26,999 | $1.8M | 50.0% |
| 2 | $67.18 | 26,999 | $1.8M | 50.0% |
| Total | $67.18 avg | 53,998 | $3.6M | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $27K | — | Filing → |
| DCPH | SELL | 2023-12-01 | $448K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $17K | — | Filing → |